Magazine
January 12, 2026
Our Roundtable Pros See More Gains for Stocks, Especially Those Left Behind Until Now
This year’s panelists offered plenty of reasons beyond AI to expect gains in 2026. Plus, 13 investment ideas.
Never Mind Venezuela. Latin America’s Future Looks Bright.
Opportunities abound in Mexico, Brazil, Chile, and more.
Long Read
Beating Back the Bubble: A Defensive Fund Portfolio for These Times
Spreading your bets among a host of different sectors can help protect you in a down market.
Long Read
Gold and Silver Funds Surged. Crypto Took a Dive.
Miner stocks did especially well in the fourth quarter, while crypto funds plunged. The other winners.
Long Read
This Stock Is Ready to Put Its Post-Covid Malaise Behind It
With tariff rules finalized and inventories depleted, there’s light at the end of the tunnel for the medical and scientific tools manufacturer.
Long Read
Retirees: Here’s How to Invest for a Fracturing World
International stocks and gold may be good bets for both gains and safety in a riskier global market.
4 minute read
Home Stocks Go Ape Over Google. Why Zillow and Others Aren’t Scared.
Housing technology companies are offering more than just listings, and their other services are a buffer against disruptions to the way buyers shop and agents advertise.
Long Read
2025 Barron’s Midyear Roundtable Picks Report Card
The S&P 500 posted a total return of 9.9% from mid-July through December 2025. Here is how Barron’s Roundtable panelists’ picks performed in the same period.
1 minute read
2025 Barron’s Roundtable Picks Report Card
The S&P 500 index returned a total 16.5% in 2025. Here is how the Barron’s Roundtable members’ picks performed.
1 minute read
Japanese Love the New Prime Minister. Markets Don’t.
Japan’s Prime Minister, Sanae Takaichi, and the Bank of Japan have a chance to steer post-deflation the country onto a stable growth path.
3 minute read
Trump’s Greenland Grab Is Already Leaving Scars
Trump’s tone-deaf approach to Greenland will damage a far more important pillar of U.S. security, Christopher Smart writes in a guest commentary.
Long Read
Cogent Biosciences Stock Soared in 2025. Four Executives Sold Shares on the Same Day.
The biotech’s chief legal and financial officers were among four executives who sold shares on the same day.
2 minute read
Columns
Departments
